A prospective observational study assessing humoral,and T cell immune responses after third doses of mRNA vaccines against SARS-CoV-2
Latest Information Update: 10 Jul 2023
At a glance
- Drugs Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics
Most Recent Events
- 10 Jul 2023 New trial record
- 03 Jun 2023 Results presented at the 24th Annual Congress of the European League Against Rheumatism